Trimeprazine tartrate
CAS No. 4330-99-8
Trimeprazine tartrate ( Alimemazine tartrate, Nedeltran, Panectyl, Repeltin, Temaril, Therafene, Theralen, Theralene )
产品货号. M14475 CAS No. 4330-99-8
It is aphenothiazine derivative that is used as an antipruritic (it prevents itching from causes such as eczema or poison ivy, by acting as an antihistamine).
纯度: >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
10MG | ¥381 | 有现货 |
|
25MG | ¥510 | 有现货 |
|
50MG | ¥721 | 有现货 |
|
100MG | ¥899 | 有现货 |
|
200MG | ¥1401 | 有现货 |
|
500MG | 获取报价 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Trimeprazine tartrate
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述It is aphenothiazine derivative that is used as an antipruritic (it prevents itching from causes such as eczema or poison ivy, by acting as an antihistamine).
-
产品描述It is aphenothiazine derivative that is used as an antipruritic (it prevents itching from causes such as eczema or poison ivy, by acting as an antihistamine).
-
同义词Alimemazine tartrate, Nedeltran, Panectyl, Repeltin, Temaril, Therafene, Theralen, Theralene
-
通路Others
-
靶点Other Targets
-
受体Others
-
研究领域——
-
适应症——
化学信息
-
CAS Number4330-99-8
-
分子量746.98
-
分子式C40H50N4O6S2
-
纯度>98%(HPLC)
-
溶解度Soluble in DMSO
-
SMILESCC(CN(C)C)CN1c2ccccc2Sc3ccccc13.CC(CN(C)C)CN4c5ccccc5Sc6ccccc46.O[C@H]([C@@H](O)C(=O)O)C(=O)O
-
化学全称10H-Phenothiazine-10-propanamine N,N,beta-trimethyl-, (R-(R*,R*))-2,3-dihydroxybutanedioate (2:1)
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Hu OY et al. The Journal of Pharmacy and Pharmacology. 38 (3): 172–6.
产品手册
关联产品
-
Niga-ichigoside F1
Niga-ichigoside F1(NI) has anti-inflammatory, gastroprotective ,antinociceptive, and cytotoxic effects.
-
Clemastanin B
Clemastanin B has antioxidant and anti-inflammatory activities, it exerts its anti-influenza activity by inhibiting the virus multiplication, prophylaxsis and blocking the virus attachment.
-
Chikusetsusaponin IV
Chikusetsusaponin IV might relieve cutaneous symptoms caused by excessive apoptotic cell death in the skin through the Fas/FasL pathway.